Mesoblast Limited
MESO
$11.60
-$0.22-1.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.67M | 5.79M | 5.90M | 6.78M | 9.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.67M | 5.79M | 5.90M | 6.78M | 9.41M |
| Cost of Revenue | 15.12M | 22.32M | 29.53M | 34.11M | 49.89M |
| Gross Profit | -9.45M | -16.54M | -23.63M | -27.32M | -40.49M |
| SG&A Expenses | 29.33M | 26.48M | 23.63M | 23.24M | 29.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 124.00K | -349.00K | -822.00K | -751.50K | -7.60M |
| Total Operating Expenses | 57.04M | 60.46M | 63.87M | 68.14M | 83.82M |
| Operating Income | -51.37M | -54.67M | -57.97M | -61.36M | -74.42M |
| Income Before Tax | -103.23M | -95.69M | -88.15M | -82.35M | -91.89M |
| Income Tax Expenses | 123.00K | -34.00K | -191.00K | -186.50K | -234.00K |
| Earnings from Continuing Operations | -103.35 | -95.65 | -87.96 | -82.17 | -91.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -103.35M | -95.65M | -87.96M | -82.17M | -91.66M |
| EBIT | -51.37M | -54.67M | -57.97M | -61.36M | -74.42M |
| EBITDA | -49.43M | -52.75M | -56.08M | -59.36M | -71.67M |
| EPS Basic | -0.09 | -0.09 | -0.09 | -0.09 | -0.11 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.05 | -0.05 | -0.07 |
| EPS Diluted | -0.09 | -0.09 | -0.09 | -0.09 | -0.11 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.05 | -0.05 | -0.07 |
| Average Basic Shares Outstanding | 4.53B | 4.26B | 3.99B | 3.81B | 4.17B |
| Average Diluted Shares Outstanding | 4.53B | 4.26B | 3.99B | 3.81B | 4.17B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
